Evidence mapPaperPMID 39844273Full record

ArticleDiabetology & metabolic syndrome2025

Are standardized conditions needed for correct CGM data interpretation in subjects at early stages of glucose intolerance?

R Dimova, N Chakarova, T Tankova

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

R DimovaDepartment of Endocrinology, Medical University of Sofia, 2 Zdrave Str., 1431, Sofia, Bulgaria. dr.roumyana.dimova@gmail.com.
N ChakarovaDepartment of Endocrinology, Medical University of Sofia, 2 Zdrave Str., 1431, Sofia, Bulgaria.
T TankovaDepartment of Endocrinology, Medical University of Sofia, 2 Zdrave Str., 1431, Sofia, Bulgaria.

Funding

EFSD Mentorship programme 2018National science fund - financial support of basic research projects - 2019 contract КП-06 Н 33/7 from 13.12.2019the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria project № BG-RRP-2.004-0004-C01
6 · The paper itself

Abstract

aimThe present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. METHODS AND

resultsSeventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m

conclusionThe trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population.

Indexed as

Continuous glucose monitoringEarly glucose intoleranceGlucose variabilityStandard conditions

Identifiers

PMID39844273
PMCPMC11899435

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.